Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.32
-0.3200-2.35%
Post-market: 13.320.00000.00%16:10 EDT
Volume:97.05K
Turnover:1.29M
Market Cap:227.85M
PE:-3.45
High:13.55
Open:13.53
Low:13.10
Close:13.64
52wk High:16.77
52wk Low:11.13
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.68
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:1.06
PE(LYR):-4.17

Loading ...

Atrium Therapeutics Publishes Investor Presentation on Precision RNA Medicines for Cardiac Diseases

Reuters
·
Jul 14

Atrium Therapeutics Wins FDA IND Clearance for ATR 1072 in Prkag2 Syndrome

Reuters
·
Jul 14

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for Atr 1072 for Treatment of Prkag2 Syndrome

THOMSON REUTERS
·
Jul 14

Atrium Therapeutics - First Participant Expected by End of 2026; Initial Data Anticipated Second Half 2027

THOMSON REUTERS
·
Jul 14

Syngenis banks $4M pre-float to power AI-driven biotech platform

The West Australian
·
Jul 13

Shanghai's Rural Spring Tourism Season Drives 260 Million Yuan in Consumption, Aiming for Sustainable Popularity

Deep News
·
Jul 08

Wave Life Sciences (WVE) Is Up 7.4% After Advancing RNA-Based Obesity Drug Into Phase 2a Trial

Simply Wall St.
·
Jul 05

Does Wave Life Sciences’ (WVE) RNA Obesity Program Signal a Shift in Its Competitive Positioning?

Simply Wall St.
·
Jun 27

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

GlobeNewswire
·
Jun 25

Does Labcorp’s New RNA At‑Home ColoSense Screening Win Shift The Bull Case For LH?

Simply Wall St.
·
Jun 24

Atrium Therapeutics grants 8 new hires stock awards including 66,000 options at $12.66

Reuters
·
Jun 24

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 24

Circio boosts share capital as it advances circular RNA therapy platform

TIPRANKS
·
Jun 22

Genflow’s Chair to Spotlight Longevity and RNA Therapeutics at BIO 2026

TIPRANKS
·
Jun 22

Avidity Biosciences Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Jun 18

TransCode Highlights Progress of Lead RNA Cancer Therapeutic

TIPRANKS
·
Jun 18

Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Jun 18

Circio raises NOK 620 million in 2026 to accelerate circular RNA gene therapy platform

TIPRANKS
·
Jun 10

Sirnaomics Sets EGM to Revamp Equity Incentive Schemes

TIPRANKS
·
Jun 09

Thalia Therapeutics Showcases RNA Strategy in European Biotech Feature

TIPRANKS
·
Jun 09